GRHL3 Inhibitors
GRHL3 inhibitors pertain to a category of chemical compounds designed to specifically target and modulate the activity of the Grainyhead-like 3 (GRHL3) protein. GRHL3 is a transcription factor belonging to the Grainyhead-like family of proteins, which play pivotal roles in regulating gene expression, cell proliferation, and differentiation. These proteins are highly conserved across species and are essential for various developmental processes and tissue homeostasis. In particular, GRHL3 is known for its critical role in the development and maintenance of epithelial tissues, which line various organs and structures within the body, including the skin, gastrointestinal tract, and respiratory system.
The inhibition of GRHL3 through specific inhibitors allows researchers to investigate the downstream effects and molecular pathways influenced by this transcription factor. By modulating GRHL3 activity, these inhibitors can be utilized as valuable tools in scientific studies to unravel the intricate mechanisms of epithelial tissue development, repair, and differentiation. Understanding the regulatory networks governed by GRHL3 can shed light on fundamental processes involved in embryogenesis, wound healing, and the maintenance of tissue integrity. Additionally, such inhibitors may have potential applications in tissue engineering and regenerative medicine by offering insights into the control of epithelial tissue formation and regeneration. Overall, GRHL3 inhibitors are instrumental in advancing our knowledge of developmental biology and tissue biology, potentially leading to novel strategies for addressing various health-related challenges.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA synthesis, potentially lowering GRHL3 mRNA levels as it impedes RNA polymerase activity. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA polymerase II activity, which could lead to a reduction in GRHL3 transcription due to general transcription inhibition. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Strongly inhibits RNA polymerase II, potentially decreasing the transcription of the GRHL3 gene. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
A nucleoside analog that can result in the premature termination of mRNA synthesis, which may indirectly reduce GRHL3 mRNA levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits the transcriptional elongation by RNA polymerase II, potentially reducing mRNA levels of genes including GRHL3. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to G-C rich DNA sequences, which might interfere with GRHL3 gene transcription if it has such sequences in its promoter. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms DNA adducts and crosslinks DNA, which can inhibit DNA synthesis and transcription, potentially affecting GRHL3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that incorporates into RNA and DNA, potentially disrupting transcription and reducing GRHL3 mRNA levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor which may lead to decreased transcription of GRHL3 by altering cell cycle-dependent signaling. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits translation and could indirectly lower GRHL3 protein levels by blocking translation initiation. | ||||||